News

NantHealth’s existing cOS, eviti and omics platforms, combined with Harris’ FusionFX® suite of products, delivers on the promise of whole health systems integration and revolutionizes the patient-clinician experience

The FDA granted orphan drug status for Anisina under the US Orphan Drug Act following a review by the agency of a package of pre-clinical data from preclinical

The company said that its bivalirudin for injection is available in a single-dose flip-top vial, which matches the current branded offering available. Additionally, Hospira intends to launch a

The agreement expands upon the strategic manufacturing alliance entered in December 2012 concerning the North Carolina facility. As part of the new deal, Eisai will transfer to Biogen

Epiduo Forte Gel is the first combination of retinoid, adapalene and benzoyl peroxide, developed for the moderate to severe acne population. Acne is the most common skin condition

The open-label, single-arm, multicenter trial showed blinatumomab monotherapy induced a complete remission or complete remission with partial hematological recovery within two cycles of treatment in a clinically meaningful

Evotaz (atazanavir 300mg and cobicistat 150mg) tablets are approved for use in combination with other antiretroviral agents to treat HIV-1 infected adults without known mutations associated with resistance

Currently, benralizumab is in Phase III development for the treatment of severe uncontrolled asthma and COPD. Benralizumab targets the IL-5 receptor and reduces eosinophils, which play a major

The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), as part of the National Institutes of Health (NIH), an agency of the United